DePuy, Inc. recently announced a recall of its ASR hip implants due to data that shows the implants are defective in a disproportionate number of patients, requiring many to undergo a second hip replacement surgery.
Many patients who received the DePuy ASR devices are contacting a lawyer to learn about their legal options. By filling out the form on this page, you will receive information about the lawsuits currently filed against DePuy Orthopaedics. Additional information regarding compensation for current or future medical expenses associated with the hip implant will also be provided.
Millions of patients with severe hip problems have chosen to undergo hip replacement surgery in order to reduce painful hip symptoms and increase their mobility. During these surgical procedures, many patients have received DePuy hip implants, which are intended to restore natural movement and alleviate hip problems.
DePuy hip implants are designed to replace or augment parts of the hip that play a key role in motion. The DePuy ASR XL total hip replacement system consists of three manmade components that are intended to act as the parts of the hip known as the acetabulum, the femoral stem and the femoral head. The DePuy ASR hip resurfacing system consists of two components including a cap that is placed over the natural femoral head and a one-piece cup that is used to replace the acetabulum.
Many patients have reported significant symptoms and side effects after receiving a DePuy hip implant. Some of the most common include:
While the symptoms above commonly occur directly after hip surgery, their long-term continuation or progression may be an indication of more serious complications.
An abnormally high amount of DePuy hip implant recipients have experienced serious complications after their initial hip replacement surgery. Some examples of these complications include:
Loosening of the Hip Implant within the Body
An abnormally large number of DePuy ASR hip implant and resurfacing system recipients have experienced serious complications after their initial surgery, such as the loosening of the implant within the body. This complication may result in limping and difficulty walking, which often causes the patient to transfer too much weight to the other hip or joints, resulting in additional pain and possible joint or bone failure.
"Metallosis" and Additional Surgeries
The DePuy ASR devices are also associated with a condition known as "metallosis," characterized by rashes and nerve damage. This condition can occur when the metal-on-metal movement of the implant causes friction and releases higher, potentially dangerous levels of chromium and cobalt ions into the body.
These complications have led to the need for a second surgery in a large number of cases.Unfortunately each additional surgery typically has a shorter life span than the previous replacement surgery.
DePuy recently announced the recall of its ASR XL Acetabular System and DePuy ASR Hip Resurfacing System. These systems first became available in July of 2003.
Recent data shows that 12 percent of patients who received the ASR resurfacing device and 13 percent of patients who received the ASR total hip replacement had to undergo a revision surgery within five years of the original operation. It was this unusually high failure rate that caused DePuy to withdraw the systems from the market. The standard failure rate for hip implants is typically 6 to 7 percent within the first five years of implantation.